Dachaigh › Tumor neuroendocrine gastro-enteropancreatic › Texas

Sgrùdaidhean clionaigeach Tumor neuroendocrine gastro-enteropancreatic ann an Texas

Tha 3 sgrùdaidhean airson Tumor neuroendocrine gastro-enteropancreatic a’ lorg phàirtichean aig làraichean ann an Texas.

Teacsa sgrùdaidh oifigeil (Beurla)

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

University of Texas - MD Anderson Cancer Center, Houston

A’ fastadhÌre 1

24 Months – 18 Years · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06441331

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Texas Oncology, Dallas

A’ fastadhÌre 3

Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06784752

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

Clinical Research Institute at Methodist Health System, Dallas

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT04090034

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.